title: [Synthesis of a supermolecular nanoparticle γ-hy-PC/Ada-Dox and its antitumor activity].
abstract: To synthesize a (2-Hydroxypropyl)-γ-cyclodextrin-polyethylenimine/adamantane-conjugated doxorubicin (γ-hy-PC/Ada-Dox) based supramolecular nanoparticle with host-guest interaction and to identify its physicochemical characterizations and antitumor effect.
  
  
  
  A novel non-viral gene delivery vector γ-hy-PC/Ada-Dox was synthesized based on host-guest interaction. 1H-NMR, NOESY, UV-Vis, XRD and TGA were used to confirm the structure of the vector. The DNA condensing ability of complexes was investigated by particle size, zeta potential and gel retardation assay. Cytotoxicity of complexes was determined by MTT assay in BEL-7402 and SMMC-7721 cells. Cell wound healing assay was performed in HEK293 and BEL-7404 cells. The transfection efficiency was investigated in HEK293 cells. H/E staining and cell uptake assay was performed in BEL-7402 cells.
  
  
  
  The structure of γ-hy-PC/Ada-Dox was characterized by 1H-NMR, NOESY, UV-Vis, XRD, TGA. The drug loading was 0.5% and 5.5%. Gel retardation assay showed that γ-hy-PC was able to completely condense DNA at N/P ratio of 2; 0.5% and 5.5% γ-hy-PC/Ada-Dox was able to completely condense DNA at N/P ratio of 3 and 4,respectively. The cytotoxicity of polymers was lower than that of PEI25KDa. The transfection efficiency of γ-hy-PC was higher than that of γ-hy-PC/Ada-Dox at N/P ratio of 30 in HEK293 cells; and the transfection efficiency was decreasing when Ada-Dox loading was increasing. Cell uptake assay showed that γ-hy-PC/Ada-Dox was able to carry drug and FAM-siRNA into cells.
  
  
  
  The novel vector γ-hy-PC/Ada-Dox has been developed successfully, which has certain transfection efficiency and antitumor activity.
authors.affiliation: Institute of Chemical Biology and Pharmaceutical Chemistry, Zhejiang University, Hangzhou, China.
authors.forename: Yong-bin
authors.initials: YB
authors.lastname: Li
authors.forename: Kai
authors.initials: K
authors.lastname: Wang
authors.forename: Tian-nan
authors.initials: TN
authors.lastname: Hu
authors.forename: Qi-wen
authors.initials: QW
authors.lastname: Wang
authors.forename: Qi-da
authors.initials: QD
authors.lastname: Hu
authors.forename: Jun
authors.initials: J
authors.lastname: Zhou
authors.forename: Xiu-rong
authors.initials: XR
authors.lastname: Hu
authors.forename: Gu-ping
authors.initials: GP
authors.lastname: Tang
mesh_terms: D000073738:2-Hydroxypropyl-beta-cyclodextrin; D000218:Adamantane / Q000008:administration & dosage* / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D045744:Cell Line, Tumor; D004317:Doxorubicin / Q000008:administration & dosage* / Q000494:pharmacology; D005822:Genetic Vectors; D006801:Humans; D053758:Nanoparticles; D011094:Polyethyleneimine; D014162:Transfection; D047392:beta-Cyclodextrins
chemical_list: D000970:Antineoplastic Agents; D047392:beta-Cyclodextrins; D000073738:2-Hydroxypropyl-beta-cyclodextrin; D004317:Doxorubicin; D011094:Polyethyleneimine; D000218:Adamantane